Medicare AdvantageCoverageMedium impact
MA11.049h, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Independence Blue Cross·Audiology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
May 27, 2026
We identified it
Jun 19, 2026
Summary
Policy MA11.049h addresses coverage and billing for Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids under Medicare Advantage plans. This is a reissue effective 05/27/2026. The billing team must review the full policy text to identify specific coverage criteria, prior authorization requirements, and applicable billing codes for these specialized hearing aid devices.
Action Required
By 05/27/2026: Billing team must obtain and review the complete policy text from the source URL to identify: (1) specific CPT or HCPCS codes for bone-anchored and implantable middle ear hearing aids, (2) prior authorization requirements, (3) medical necessity documentation requirements, and (4) coverage limitations. Update billing system rules, encounter forms, and provider education materials accordingly. Providers should be notified of any new prior auth workflows. Without proper implementation, claims for these devices will be denied or delayed.